Surface Oncology, Inc. Common Stock
SURF
SURF was delisted on the 7th of September, 2023.
47 hedge funds and large institutions have $44.4M invested in Surface Oncology, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 54 → 47 (-7)
40% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 20
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
43% less capital invested
Capital invested by funds: $78.4M → $44.4M (-$34M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$2.27M |
| 2 |
Millennium Management
New York
|
+$839K |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$196K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$169K |
| 5 |
Jane Street
New York
|
+$116K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.96M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.08M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$676K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$604K |
| 5 |
State Street
Boston,
Massachusetts
|
-$483K |
SURF Hedge Fund Activity: Q2 2019 in Review
47 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q2 2019, worth a combined $44.4M — down 43% from $78.4M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of SURF and 8 opened new positions — a net loss of 6 holders — while 20 trimmed existing stakes and 12 added.
The largest buyer was BVF Inc, adding an estimated $2.27M. The largest seller was BlackRock, cutting an estimated $1.96M.
- 47 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q2 2019, down from 54 in Q1 2019.
- Funds reported $44.4M of Surface Oncology, Inc. Common Stock stock for Q2 2019, down 43% quarter-over-quarter.
- 8 funds opened new Surface Oncology, Inc. Common Stock positions in Q2 2019 and 14 closed out, a net change of -6 holders.
- The largest Surface Oncology, Inc. Common Stock buyer in Q2 2019 was BVF Inc, an estimated $2.27M added.
- The largest Surface Oncology, Inc. Common Stock seller in Q2 2019 was BlackRock, an estimated $1.96M sold.
Based on aggregated 13F filings for Q2 2019.